OMNI BIO PHARMACEUTICAL, INC.

Highlights Omni Bio Pharmaceutical, Inc.

Equities

OMBP

US68216L1008

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+66.67%	+233.33%

2016	Omni Bio Pharmaceutical, Inc. cancelled the transaction announced on March 16, 2015	CI
2015	Omni Bio Pharmaceutical, Inc. Announces Management Changes	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Omni Bio Pharmaceutical, Inc. Announces Clinical Data for Use of Alpha-1 Antitrypsin in Steroid-Resistant Graft Versus Host Disease	09/12/14	CI
Omni Bio Pharmaceutical, Inc. Announces Presentation of Phase 1/2 Clinical Data for AAT at American Heart Association Scientific Sessions	19/11/14	CI
Omni Bio Successfully Completes Cell Line Optimization for Novel Recombinant Biologic	18/11/14	CI
Omni Bio Pharmaceutical, Inc. Announces Publication of Its Pilot Study of Alpha-1 Antitrypsin in Type 1 Diabetes	30/04/14	CI
Gallus BioPharmaceuticals, LLC Enters Cell Line Optimization and Manufacturing Agreement with Omni Bio Pharmaceutical, Inc	29/04/14	CI
Omni Bio Pharmaceutical, Inc. Receives Notice of Allowance for the Use of Alpha-1 Antitrypsin to Reduce Risk of Non-Organ Transplant Rejection and to Treat Graft Versus Host Disease	26/11/13	CI
Omni Bio Pharmaceutical, Inc. Announces Reduction in Inflammatory Myocardial Injury with its Lead Recombinant Molecule	20/11/13	CI
Omni Bio Pharmaceutical, Inc. Receives Notice of Allowance for its First U.S. Patent Action for Recombinant Alpha-1 Antitrypsin Molecule	06/11/13	CI
Omni Bio Pharmaceutical, Inc. Announces First Results for its Lead Recombinant Molecule	15/03/13	CI
Omni Bio Pharmaceutical, Inc. Announces Type 1 Diabetes Trial Results	30/05/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer